イリノイ州における潰瘍性大腸炎の臨床試験
イリノイ州内の拠点で、潰瘍性大腸炎に関する24件の研究が参加者を募集しています。
イリノイ州内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines
- Gi Alliance - Glenview /ID# 283932, Glenview
- Illinois Gastroenterology Group /ID# 283933, Gurnee
- 他1件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Yapp, Rockford M.D. (Private Practice), Downers Grove
- GI Alliance - Glenview, Glenview
- Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington
- 他3件
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Chicago Medical Center /ID# 271588, Chicago
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/30更新 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 038, Chicago
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-005, Des Plaines
- Site US-007, Glenview
- Site US-020, Gurnee
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Chicago Medical Center, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06979336A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0101, Park Ridge
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Rush University Medical Center, Chicago
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Center for Gastrointestinal Health - Fairview Heights, Belleville
- Northwestern University, Chicago
- Midtown Gastroenterology and Liver Disease, Des Plaines
- 他2件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Midwest Digestive Health & Nutrition, Des Plaines
- 他1件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Chicago Medicine, Chicago
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Illinois Gastroenterology Group - Gurnee, Gurnee
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Rush University Medical Center - Site Number: 8400015, Chicago
- Midwest Digestive Health and Nutrition - Site Number: 8400136, Des Plaines
- GI Alliance - Glenview - Site Number: 8400068, Glenview
- 他1件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Chicago Medicine, Chicago
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Suburban Gastroenterology Ltd, Naperville
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University of Chicago Medical Center, Chicago
被験者募集中第2相
12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital Park Ridge, Park Ridge
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
- Northwestern University, Chicago
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/05/22更新 · NCT07427017A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital - Park Ridge - PIN, Park Ridge
被験者募集中第3相
2歳以上 · 全性別 · 2026/05/07更新 · NCT05442567STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
- University of Chicago, Chicago
被験者募集中
18歳〜75歳 · 全性別 · 2026/04/06更新 · NCT06693310A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Glenview
- Mirador Therapeutics Selected Site, Gurnee
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Northwestern Medicine Lake Forest Hospital, Lake Forest
被験者募集中
18歳〜85歳 · 全性別 · 2026/01/08更新 · NCT05987852ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。